PE20030136A1 - Tabletas bioadhesivas para hidratacion progresiva - Google Patents
Tabletas bioadhesivas para hidratacion progresivaInfo
- Publication number
- PE20030136A1 PE20030136A1 PE2001000582A PE2001000582A PE20030136A1 PE 20030136 A1 PE20030136 A1 PE 20030136A1 PE 2001000582 A PE2001000582 A PE 2001000582A PE 2001000582 A PE2001000582 A PE 2001000582A PE 20030136 A1 PE20030136 A1 PE 20030136A1
- Authority
- PE
- Peru
- Prior art keywords
- water
- progressive hydration
- polymer
- composition
- sponged
- Prior art date
Links
- 239000000227 bioadhesive Substances 0.000 title abstract 2
- 230000036571 hydration Effects 0.000 title abstract 2
- 238000006703 hydration reaction Methods 0.000 title abstract 2
- 230000000750 progressive effect Effects 0.000 title abstract 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 2
- 229920000642 polymer Polymers 0.000 abstract 2
- 229960003604 testosterone Drugs 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- 229920003169 water-soluble polymer Polymers 0.000 abstract 2
- XWTYSIMOBUGWOL-UHFFFAOYSA-N (+-)-Terbutaline Chemical compound CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1 XWTYSIMOBUGWOL-UHFFFAOYSA-N 0.000 abstract 1
- 229940031663 carbomer-974p Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229960000195 terbutaline Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
SE REFIERE A UNA COMPOSICION FARMACEUTICA BIOADHESIVA PARA HIDRATACION PROGRESIVA QUE COMPRENDE: a) UNA CANTIDAD EFECTIVA DE TESTOSTERONA; b) UN POLIMERO POLICARBOXILICO INSOLUBLE, DEGRADABLE QUE SE PUEDE ESPONJAR CON AGUA COMO POLICARBOFIL; c) UN POLIMERO HIDROSOLUBLE (CARBOMERO 974P) . LA TESTOSTERONA ESTA PRESENTE EN 30 mg POR DOSIS UNITARIA DE LA COMPOSICION. SE REFIERE TAMBIEN A UNA COMPOSICION QUE COMPRENDE TERBUTALINA, UN POLIMERO POLICARBOXILICO INSOLUBLE DEGRADABLE QUE SE PUEDE ESPONJAR CON AGUA Y UN POLIMERO HIDROSOLUBLE
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US59607300A | 2000-06-16 | 2000-06-16 | |
| US09/877,218 US6624200B2 (en) | 1998-08-25 | 2001-06-11 | Bioadhesive progressive hydration tablets |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20030136A1 true PE20030136A1 (es) | 2003-03-18 |
Family
ID=24385886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2001000582A PE20030136A1 (es) | 2000-06-16 | 2001-06-15 | Tabletas bioadhesivas para hidratacion progresiva |
Country Status (4)
| Country | Link |
|---|---|
| CO (1) | CO5270003A1 (es) |
| PE (1) | PE20030136A1 (es) |
| TW (2) | TWI311916B (es) |
| ZA (1) | ZA200104935B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI554708B (zh) | 2015-11-11 | 2016-10-21 | 宣明智 | 微型裝置的固定元件及微型裝置 |
-
2001
- 2001-03-15 TW TW090106120A patent/TWI311916B/zh not_active IP Right Cessation
- 2001-06-14 TW TW090114486A patent/TWI319987B/zh not_active IP Right Cessation
- 2001-06-15 CO CO01048291A patent/CO5270003A1/es not_active Application Discontinuation
- 2001-06-15 ZA ZA200104935A patent/ZA200104935B/xx unknown
- 2001-06-15 PE PE2001000582A patent/PE20030136A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TWI311916B (en) | 2009-07-11 |
| TWI319987B (en) | 2010-02-01 |
| ZA200104935B (en) | 2002-12-11 |
| CO5270003A1 (es) | 2003-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR032352A1 (es) | Composicion farmaceutica bioadhesiva de hidratacion gradual y su uso en la fabricacion de un medicamento para la administracion de testosterona y terbutalina a un mamifero a traves de una superficie de mucosa. | |
| NZ336789A (en) | Use of methacrylic acid copolymer type C in the manufacture of tablets | |
| CO5261517A1 (es) | Composiciones farmaceuticas analgesicas que contienen buprenorfina/naloxona, buprenorfina/naltrexona o buprenorfina/nalmefen en bajas dosis | |
| ES2128369T3 (es) | Procedimiento para la fabricacion de formas farmaceuticas solidas con liberacion prolongada en dos etapas. | |
| PA8509001A1 (es) | Forma de dosificacion de farmacos accionada por un hidrogel | |
| ES2178876T3 (es) | Pastillas de desintegracion rapida. | |
| PE20050775A1 (es) | Formulaciones que comprenden multiparticulas de liberacion controlada | |
| DOP2001000241A (es) | Formulaciones de liberación sostenida para secretagogos de hormona del crecimiento | |
| AR028299A1 (es) | Una composicion farmaceutica que comprende nateglinida, un proceso para su preparacion y el uso de dicha composicion para la preparacion de un medicamento para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con diabetes. | |
| TW200633730A (en) | Oral disintegrating dosage forms | |
| PA8562201A1 (es) | Formulaciones de acitromicina directamente compresibles | |
| PE20010952A1 (es) | Composicion para dosis oral de liberacion extendida | |
| CO5190688A1 (es) | Formas farmaceuticas de administracion oral al menos parcialmente retardadas cuya sustancia activa tramadol se encuentra al menos parcialmente en forma de compuesto formado in situ con una hidrosolubilidad 100 mg/ml, y procedimientos para su preparac | |
| ES2177346T3 (es) | Formulaciones de ranolazina de liberacion lenta. | |
| CA2716874A1 (en) | A pharmaceutical composition and its use in the preparation of a medicament for the treatment of cerebrovascular diseases | |
| ES2111547T3 (es) | Comprimido de liberacion prolongada. | |
| CO5251434A1 (es) | Composicion de liberacion controlada | |
| BR0307278A (pt) | Formulação oral de liberação imediata, e, método para preparar uma formulação | |
| CO5540295A2 (es) | Comprimido para tragar que comprende paracetamol | |
| ES2099021B1 (es) | Composicion farmaceutica que tiene actividad analgesica. | |
| PE20030136A1 (es) | Tabletas bioadhesivas para hidratacion progresiva | |
| AR052322A1 (es) | Compuestos de n-benzoil-estaurosporina, procesos para su preparacion y composicion farmaceutica | |
| AR026010A1 (es) | Unidad de dosificacion oral que se desintegra oralmente conteniendo como ingrediente activo el antidepresivo mirtazapina | |
| DE602004014964D1 (de) | Pharmazeutische zusammensetzung mit einem kationischen hilfsmittel | |
| ATE163265T1 (de) | Asserlösliche pharmazeutische zusammensetzungen, die östronderivate und kalziumsalze enthalten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |